Scott Liebman > Sheppard, Mullin, Richter & Hampton LLP > New York, United States > Lawyer Profile
Sheppard, Mullin, Richter & Hampton LLP Offices
30 ROCKEFELLER PLAZA
NEW YORK, NY 10112
NEW YORK
United States
- Firm Profile
- Go to...
Scott Liebman
Work Department
Life Sciences
Position
Scott Liebman is leader of the firm’s Life Sciences team and is based in the firm’s New York office.
Scott focuses on complex FDA regulatory, compliance and legal matters affecting global pharmaceutical, biotechnology and medical device manufacturers. He counsels clients on federal and state requirements and develops legal and regulatory strategies to help commercialize their products.
Clients regularly turn to Scott and his team to support product launches; implement corporate integrity agreements; develop comprehensive training and monitor compliance programs; and handle anti-kickback, sampling and off-label investigations. Whether advising executives or training a national sales force, Scott knows that clear, thoughtful communication and practical advice are key to supporting his clients.
He has worked with businesses of all sizes, from small life sciences organizations launching their first product to Fortune 500 companies in the pharmaceutical and medical products/equipment industries. His clients operate worldwide and include Europe- and Asia-based life sciences companies.
Scott is passionate about understanding his clients’ challenges and is committed to learning their businesses inside and out to find solutions. He brings deep technical knowledge along with enthusiasm for his clients’ work to each client relationship.
Education
J.D., Seton Hall University Law School
B.A., Lehigh University
Lawyer Rankings
United States > Healthcare > Life sciences
Sheppard, Mullin, Richter & Hampton LLP‘s ‘flexible and business oriented’ practice assists clients with the management of their patent portfolios, advising on patent prosecution strategies and representing them in court where infringements occur, while also supporting clients in negotiations with the FDA over labelling issues and approvals for novel drugs. Based in New York, the practice leadership consists of Jeffrey Fessler, who focuses on life sciences transactions, and Scott Liebman, who accompanies pharmaceutical, biotech and medical devices clients through FDA procedures. Former team co-head Allison Fulton took up an in house post in February 2023.
Lawyer Rankings
Top Tier Firm Rankings
Firm Rankings
- Government > Government contracts
- Healthcare > Health insurers
- Real estate > Land use/zoning
- M&A/corporate and commercial > M&A: middle-market (sub-$500m)
- Media, technology and telecoms > Media and entertainment: transactional
- Tax > Not-for-profit (Fortune 1000 private foundations, national trade associations, and charities)
- Energy > Renewable/alternative power
- Healthcare > Service providers
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Real estate > Real estate
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Environment > Environment: litigation
- Labor and employment > Labor and employment disputes (including collective actions)
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Real estate > Construction (including construction litigation)
- Healthcare > Life sciences
- Real estate > Real estate finance
- Insurance > Advice to insurers